{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:28:22Z","timestamp":1793384902150,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Health and Medical Research Council of Australia","award":["APP1128849"],"award-info":[{"award-number":["APP1128849"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.neurobiolaging.2019.03.015","type":"journal-article","created":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T11:04:55Z","timestamp":1554116695000},"page":"11-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":127,"special_numbering":"C","title":["Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-\u03b2 and tau"],"prefix":"10.1016","volume":"80","author":[{"given":"Kelly R.","family":"Jacobs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chai K.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratishtha","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph N.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce J.","family":"Brew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8105-4470","authenticated-orcid":false,"given":"Gilles J.","family":"Guillemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Lovejoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib1","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.bcp.2012.12.014","article-title":"Kynurenic acid as an Antagonist of \u03b17 nicotinic acetylcholine receptors in the brain: facts and challenges","volume":"85","author":"Albuquerque","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/archneur.56.6.673","article-title":"Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease","volume":"56","author":"Andreasen","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s007020050149","article-title":"Kynurenine metabolism in Alzheimer's disease","volume":"106","author":"Baran","year":"1999","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib5","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1042\/bst0130441","article-title":"Kynurenine hydroxylase: a potential rate-limiting enzyme in tryptophan metabolism","volume":"13","author":"Bender","year":"1985","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"Blennow","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02815140","article-title":"Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?","volume":"26","author":"Blennow","year":"1995","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1179\/174329210X12650506623645","article-title":"Indoleamine 2,3-dioxygenase and 3OH-kynurenine modifications are found in the neuropathology of alzheimer disease","volume":"15","author":"Bonda","year":"2010","journal-title":"Redox Rep."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib9","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s12640-019-9997-4","article-title":"Kynurenine 3-monooxygenase activity in human primary neurons and effect on cellular bioenergetics identifies new neurotoxic mechanisms","volume":"35","author":"Castellano-Gonzalez","year":"2019","journal-title":"Neurotox Res."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib10","doi-asserted-by":"crossref","first-page":"8008","DOI":"10.1038\/s41598-018-25968-7","article-title":"Alterations in serum kynurenine pathway metabolites in individuals with high neocortical amyloid-\u03b2 load: a pilot study","volume":"8","author":"Chatterjee","year":"2018","journal-title":"Scientific Rep."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2014.09.034","article-title":"The Janus faces of 3-hydroxykynurenine: dual redox modulatory activity and lack of neurotoxicity in the rat striatum","volume":"1589","author":"Col\u00edn-Gonz\u00e1lez","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4137\/IJTR.S4282","article-title":"On the biological importance of the 3-hydroxyanthranilic acid: anthranilic acid ratio","volume":"3","author":"Darlington","year":"2010","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib13","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/aps.2009.24","article-title":"Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases","volume":"30","author":"Dong","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib14","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","article-title":"Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism","volume":"56","author":"Fukui","year":"1991","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib15","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3233\/JAD-170485","article-title":"Kynurenine pathway metabolites in Alzheimer's disease","volume":"60","author":"Giil","year":"2017","journal-title":"J.\u00a0Alzheimer's Dis."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib16","doi-asserted-by":"crossref","first-page":"7266","DOI":"10.1021\/bi992997s","article-title":"3-Hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote alpha-crystallin cross-linking by metal ion reduction","volume":"39","author":"Goldstein","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4137\/IJTR.S2469","article-title":"The physiological action of picolinic acid in the human brain","volume":"2","author":"Grant","year":"2009","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.nbd.2004.07.006","article-title":"Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease","volume":"17","author":"Guidetti","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib19","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nbd.2006.02.011","article-title":"Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice","volume":"23","author":"Guidetti","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib20","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1742-4658.2012.08485.x","article-title":"Quinolinic acid, the inescapable neurotoxin","volume":"279","author":"Guillemin","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/glia.20090","article-title":"Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons","volume":"49","author":"Guillemin","year":"2004","journal-title":"Glia"},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4615-0135-0_12","article-title":"Expression of the kynurenine pathway enzymes in human microglia and macrophages","volume":"527","author":"Guillemin","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib23","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1471-4159.2001.00498.x","article-title":"Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection","volume":"78","author":"Guillemin","year":"2001","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib24","doi-asserted-by":"crossref","first-page":"12884","DOI":"10.1523\/JNEUROSCI.4101-07.2007","article-title":"Characterization of the kynurenine pathway in human neurons","volume":"27","author":"Guillemin","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib25","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2478\/v10039-010-0023-6","article-title":"Kynurenine and its metabolites in Alzheimer's disease patients","volume":"55","author":"Gulaj","year":"2010","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib26","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/00005072-199311000-00012","article-title":"Plaque-only Alzheimer disease is usually the lewy body variant, and vice versa","volume":"52","author":"Hansen","year":"1993","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib27","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib29","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.2174\/0929867324666170502123114","article-title":"Major developments in the design of inhibitors along the kynurenine pathway","volume":"24","author":"Jacobs","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib30","doi-asserted-by":"crossref","first-page":"e0131389","DOI":"10.1371\/journal.pone.0131389","article-title":"Expression of the kynurenine pathway in human peripheral blood mononuclear cells: implications for inflammatory and neurodegenerative disease","volume":"10","author":"Jones","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib31","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.ajpath.2011.05.048","article-title":"The tryptophan metabolite 3-hydroxyanthranilic acid plays anti-inflammatory and neuroprotective roles during inflammation: role of hemeoxygenase-1","volume":"179","author":"Krause","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neuint.2006.04.017","article-title":"In\u00a0vitro evidence for an antioxidant role of 3-hydroxykynurenine and 3-hydroxyanthranilic acid in the brain","volume":"50","author":"Leipnitz","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib33","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/mds.25555","article-title":"3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis","volume":"28","author":"LeWitt","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib34","doi-asserted-by":"crossref","first-page":"41473","DOI":"10.1038\/srep41473","article-title":"Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression","volume":"7","author":"Lim","year":"2017","journal-title":"Scientific Rep."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/1871524915666141216161246","article-title":"Plasma metabolic profiling of mild cognitive impairment and Alzheimer's disease using liquid chromatography\/mass spectrometry","volume":"14","author":"Liu","year":"2014","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib36","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.expneurol.2012.10.007","article-title":"Astrocytes: conductors of the Alzheimer disease neuroinflammatory symphony","volume":"239","author":"Medeiros","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1503\/jpn.120166","article-title":"Searching for an endogenous anti-Alzheimer molecule: identifying small molecules in the brain that slow Alzheimer disease progression by inhibition of ss-amyloid aggregation","volume":"38","author":"Meek","year":"2013","journal-title":"J.\u00a0Psychiatry Neurosci."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib38","doi-asserted-by":"crossref","first-page":"e536","DOI":"10.1371\/journal.pone.0000536","article-title":"Mitochondrial oxidative stress causes hyperphosphorylation of tau","volume":"2","author":"Melov","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib39","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nature06616","article-title":"Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease","volume":"451","author":"Meyer-Luehmann","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib40","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1212\/WNL.42.9.1702","article-title":"Kynurenine pathway abnormalities in Parkinson's disease","volume":"42","author":"Ogawa","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib41","doi-asserted-by":"crossref","first-page":"12553","DOI":"10.1073\/pnas.93.22.12553","article-title":"Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine","volume":"93","author":"Okuda","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.pneurobio.2016.01.001","article-title":"Astrogliosis: an integral player in the pathogenesis of Alzheimer's disease","volume":"144","author":"Osborn","year":"2016","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib43","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/jamaneurol.2014.1358","article-title":"Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid beta-amyloid 42: a cross-validation study against amyloid positron emission tomography","volume":"71","author":"Palmqvist","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib44","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1742-4658.2007.05635.x","article-title":"Tissue expression and biochemical characterization of human 2-amino 3-carboxymuconate 6-semialdehyde decarboxylase, a key enzyme in tryptophan catabolism","volume":"274","author":"Pucci","year":"2007","journal-title":"FEBS J"},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib45","doi-asserted-by":"crossref","first-page":"e6344","DOI":"10.1371\/journal.pone.0006344","article-title":"The excitotoxin quinolinic acid induces tau phosphorylation in human neurons","volume":"4","author":"Rahman","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib46","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/mp.2009.116","article-title":"CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression","volume":"15","author":"Raison","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4137\/IJTR.S2129","article-title":"L-tryptophan: basic metabolic functions, behavioral Research and therapeutic indications","volume":"2","author":"Richard","year":"2009","journal-title":"Int. J. Tryptophan Res. : IJTR"},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib48","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0531-5565(00)00148-0","article-title":"Heme oxygenase-1: role in brain aging and neurodegeneration","volume":"35","author":"Schipper","year":"2000","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00406-012-0384-x","article-title":"Increased 3-Hydroxykynurenine serum concentrations differentiate Alzheimer\u2019s disease patients from controls","volume":"263","author":"Schwarz","year":"2013","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib50","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.neulet.2009.11.010","article-title":"Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells","volume":"468","author":"Su","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3940(00)01036-3","article-title":"Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization","volume":"285","author":"Vanmechelen","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib52","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s007020050029","article-title":"Tryptophan degradation and immune activation in Alzheimer's disease","volume":"107","author":"Widner","year":"2000","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib53","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1515\/pteridines.1999.10.3.101","article-title":"The importance of neopterin as a laboratory diagnostic marker of immune activation","volume":"10","author":"Widner","year":"1999","journal-title":"Pteridines"},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib54","doi-asserted-by":"crossref","first-page":"316523","DOI":"10.1155\/2013\/316523","article-title":"Oxidative stress and the pathogenesis of Alzheimer's disease","volume":"2013","author":"Zhao","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib55","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1385\/MN:31:1-3:205","article-title":"Oxidative imbalance in alzheimer\u2019s disease","volume":"31","author":"Zhu","year":"2005","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2019.03.015_bib56","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cell.2011.05.020","article-title":"Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration","volume":"145","author":"Zwilling","year":"2011","journal-title":"Cell"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458019301009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458019301009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:28:23Z","timestamp":1759318103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458019301009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":56,"alternative-id":["S0197458019301009"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.03.015","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-\u03b2 and tau","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}